IL74949A - Iron complexes with hydroxypyrone or hydroxypyridone derivatives,their preparation and pharmaceutical compositions and containing them - Google Patents
Iron complexes with hydroxypyrone or hydroxypyridone derivatives,their preparation and pharmaceutical compositions and containing themInfo
- Publication number
- IL74949A IL74949A IL74949A IL7494985A IL74949A IL 74949 A IL74949 A IL 74949A IL 74949 A IL74949 A IL 74949A IL 7494985 A IL7494985 A IL 7494985A IL 74949 A IL74949 A IL 74949A
- Authority
- IL
- Israel
- Prior art keywords
- hydroxypyrone
- preparation
- pharmaceutical compositions
- iron complexes
- hydroxypyridone derivatives
- Prior art date
Links
- LIPRKYKMVQPYPG-UHFFFAOYSA-N 3-Hydroxy-2H-pyran-2-one Chemical compound OC1=CC=COC1=O LIPRKYKMVQPYPG-UHFFFAOYSA-N 0.000 title 1
- 150000002505 iron Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- GGOZGYRTNQBSSA-UHFFFAOYSA-N pyridine-2,3-diol Chemical class OC1=CC=CN=C1O GGOZGYRTNQBSSA-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/62—Three oxygen atoms, e.g. ascorbic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
- C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/02—Iron compounds
- C07F15/025—Iron compounds without a metal-carbon linkage
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Pyrane Compounds (AREA)
- Conveying Record Carriers (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB848410289A GB8410289D0 (en) | 1984-04-19 | 1984-04-19 | Pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL74949A true IL74949A (en) | 1988-05-31 |
Family
ID=10559910
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL74949A IL74949A (en) | 1984-04-19 | 1985-04-17 | Iron complexes with hydroxypyrone or hydroxypyridone derivatives,their preparation and pharmaceutical compositions and containing them |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0159194B1 (da) |
| JP (1) | JPH0794467B2 (da) |
| AU (1) | AU582153B2 (da) |
| CA (1) | CA1286844C (da) |
| CY (1) | CY1575A (da) |
| DE (1) | DE3579730D1 (da) |
| DK (1) | DK160986C (da) |
| GB (2) | GB8410289D0 (da) |
| HK (1) | HK8091A (da) |
| IE (1) | IE58667B1 (da) |
| IL (1) | IL74949A (da) |
| NZ (1) | NZ211788A (da) |
| PH (1) | PH25348A (da) |
| SG (1) | SG92490G (da) |
| ZA (1) | ZA852830B (da) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8329043D0 (en) * | 1983-10-31 | 1983-11-30 | Hider R C | Pharmaceutical compositions |
| CA1283404C (en) * | 1986-07-01 | 1991-04-23 | Shigeru Sanai | Cephalosporin compounds, processes for their preparation and antibacterial agents |
| US4908371A (en) * | 1987-11-10 | 1990-03-13 | Ciba-Geigy Corporation | Esterified hydroxy dihydropyridinones for treating diseases associated with trivalent metal ion overload |
| ES2047149T3 (es) * | 1988-01-20 | 1994-02-16 | Ciba Geigy Ag | Procedimiento para la obtencion de compuestos complejos. |
| JPH03101676A (ja) * | 1989-09-14 | 1991-04-26 | Sansho Seiyaku Co Ltd | ２―エトキシメチル―５―ヒドロキシ―γ―ピロン及び同化合物を有効成分とするメラニン生成抑制外用剤 |
| AU7346091A (en) * | 1990-03-02 | 1991-09-18 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Preparations for mr diagnosis |
| EP0833627B1 (en) | 1995-06-10 | 2004-08-18 | Vitra Pharmaceuticals Ltd. | Iron compounds, compositions, methods of making the same and uses thereof |
| GB9621273D0 (en) | 1996-10-11 | 1996-11-27 | Cortecs Ltd | Therapeutic method |
| EP1318804B1 (en) | 2000-09-19 | 2004-11-17 | Vitra Pharmaceuticals Ltd. | Iron compositions |
| GB0211500D0 (en) | 2002-05-18 | 2002-06-26 | Vitra Pharmaceuticals Ltd | Method of forming iron hydroxypyrone compounds |
| ES2660202T3 (es) | 2010-03-23 | 2018-03-21 | Vifor (International) Ag | Compuestos del complejo Fe (iii) para el tratamiento y la profilaxis de los síntomas de deficiencia de hierro y las anemias ferropénicas |
| GB201101370D0 (en) | 2011-01-27 | 2011-03-09 | Iron Therapeutics Holdings Ag | Process |
| PE20141319A1 (es) | 2011-03-29 | 2014-10-29 | Vifor Int Ag | Compuesto de complejos de fe(iii) para el tratamiento y profilaxis de sintomas de deficiencia de hierro y anemias por deficiencia de hierro |
| US20140248342A1 (en) | 2011-05-31 | 2014-09-04 | Vifor (International) Ag | Fe(III) 2,4-Dioxo-1-Carbonyl Complexes For Treatment And Prophylaxis Of Iron Deficiency Symptoms And Iron Deficiency Anaemias |
| KR101798605B1 (ko) | 2012-12-21 | 2017-11-16 | 비포르 (인터내셔날) 아게 | 철 결핍 증상 및 철 결핍성 빈혈의 치료 및 예방을 위한 Fe(III) 착화합물 |
| AU2017242906B2 (en) * | 2016-03-31 | 2020-11-19 | Shield TX (UK) Limited | Methods for producing Ferric maltol compositions from Ferrous Hydroxides |
| CN109071481B (zh) * | 2016-03-31 | 2022-09-30 | 英国神盾Tx股份有限公司 | 用于由元素铁产生麦芽酚铁组合物的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2117766B (en) * | 1982-03-24 | 1985-08-29 | Nat Res Dev | Pharmaceutical compositions |
| US4550101A (en) * | 1982-03-24 | 1985-10-29 | National Research Development Corporation | Iron complexes of hydroxy pyridones useful for treating iron deficiency anemia |
| EP0107458B1 (en) * | 1982-10-22 | 1987-07-29 | National Research Development Corporation | Pharmaceutical compositions |
| GB8308055D0 (en) * | 1983-03-24 | 1983-05-05 | Hider R C | Pharmaceutical compositions |
-
1984
- 1984-04-19 GB GB848410289A patent/GB8410289D0/en active Pending
-
1985
- 1985-04-10 PH PH32121A patent/PH25348A/en unknown
- 1985-04-15 CA CA000479100A patent/CA1286844C/en not_active Expired - Lifetime
- 1985-04-15 NZ NZ211788A patent/NZ211788A/xx unknown
- 1985-04-16 ZA ZA852830A patent/ZA852830B/xx unknown
- 1985-04-17 DE DE8585302706T patent/DE3579730D1/de not_active Expired - Lifetime
- 1985-04-17 GB GB08509813A patent/GB2157686B/en not_active Expired
- 1985-04-17 IL IL74949A patent/IL74949A/xx not_active IP Right Cessation
- 1985-04-17 EP EP85302706A patent/EP0159194B1/en not_active Expired - Lifetime
- 1985-04-18 IE IE99285A patent/IE58667B1/en not_active IP Right Cessation
- 1985-04-18 AU AU41413/85A patent/AU582153B2/en not_active Ceased
- 1985-04-18 DK DK175585A patent/DK160986C/da not_active IP Right Cessation
- 1985-04-19 JP JP60085302A patent/JPH0794467B2/ja not_active Expired - Lifetime
-
1990
- 1990-11-13 SG SG924/90A patent/SG92490G/en unknown
-
1991
- 1991-01-24 HK HK80/91A patent/HK8091A/xx not_active IP Right Cessation
- 1991-12-20 CY CY1575A patent/CY1575A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA1286844C (en) | 1991-07-23 |
| GB8410289D0 (en) | 1984-05-31 |
| AU4141385A (en) | 1985-10-24 |
| GB2157686A (en) | 1985-10-30 |
| IE58667B1 (en) | 1993-11-03 |
| GB2157686B (en) | 1987-12-16 |
| ZA852830B (en) | 1986-12-30 |
| DK160986C (da) | 1991-11-11 |
| JPH0794467B2 (ja) | 1995-10-11 |
| NZ211788A (en) | 1988-06-30 |
| EP0159194A2 (en) | 1985-10-23 |
| DK160986B (da) | 1991-05-13 |
| GB8509813D0 (en) | 1985-05-22 |
| DK175585A (da) | 1985-10-20 |
| JPS60248696A (ja) | 1985-12-09 |
| AU582153B2 (en) | 1989-03-16 |
| EP0159194B1 (en) | 1990-09-19 |
| EP0159194A3 (en) | 1986-03-12 |
| SG92490G (en) | 1991-02-14 |
| IE850992L (en) | 1985-10-19 |
| CY1575A (en) | 1991-12-20 |
| DK175585D0 (da) | 1985-04-18 |
| DE3579730D1 (de) | 1990-10-25 |
| PH25348A (en) | 1991-05-13 |
| HK8091A (en) | 1991-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL74950A (en) | Pharmaceutical compositions comprising iron complexes with hydroxypyrone derivatives | |
| EP0120669A3 (en) | Hydroxypyridones, and their pharmaceutical compositions | |
| NZ212805A (en) | Quinoline, naphthydridine and benzoxazene derivatives and pharmaceutical compositions | |
| ZA855939B (en) | 3-acylaminomethylimidazo(1,2-a)pyridine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL76405A0 (en) | 1,3-diacyl-2-oxyindole derivatives,their preparation and pharmaceutical compositions containing them | |
| IL74949A (en) | Iron complexes with hydroxypyrone or hydroxypyridone derivatives,their preparation and pharmaceutical compositions and containing them | |
| IL71243A0 (en) | Furo-(3,4-c)-pyridine derivatives,their preparation and pharmaceutical compositions containing them | |
| DE3475706D1 (en) | Iron iii complexes of hydroxypyridones, and their pharmaceutical compositions | |
| ZA848130B (en) | New 6-vinyl-furo-(3,4-c)-pyridine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL74244A (en) | Quinoline derivatives,their preparation and pharmaceutical compositions containing them | |
| NZ212956A (en) | Pyridine derivatives and pharmaceutical compositions | |
| IL76894A0 (en) | Tricyclic pyridine derivatives,their manufacture and pharmaceutical compositions containing them | |
| IL83049A0 (en) | 4-pyridone derivatives,their manufacture and pharmaceutical compositions containing them | |
| IL86394A0 (en) | Pyridine derivatives,their manufacture and pharmaceutical compositions containing them | |
| IL75825A0 (en) | Phenylquinoline derivatives,their preparation and pharmaceutical compositions containing them | |
| EP0159652A3 (en) | 4-phenylphthalazine derivatives, their preparation and pharmaceutical compositions containing them | |
| IL73509A (en) | 1,4-dihydro-3-carbamoyl pyridines,their preparation and pharmaceutical compositions comprising them | |
| IL76312A (en) | Xenocoumacins and derivatives thereof,their preparation and pharmaceutical compositions containing them | |
| IL91087A0 (en) | Platinum-(iv)-diamine complexes,their preparation and pharmaceutical compositions containing them | |
| NZ212976A (en) | Amino-anthracenedione-platinum complexes and anti-cancer compositions | |
| IL72239A (en) | 1,5-diphenylpent-1-en-4-yne derivatives,and anticancer pharmaceutical compositions containing them | |
| DE3561808D1 (en) | Phenylnonatetraenic-acid derivatives, their preparation and pharmaceutical compositions containing them | |
| IL73810A (en) | 4,5,6,7-tetrahydrothiazolo-(5,4-c)pyridine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL96252A0 (en) | Pyridine derivatives,their preparation and pharmaceutical compositions containing them | |
| ZA858004B (en) | 6-phenethylaminoalkyl-furo-(3,4-c)-pyridine derivatives,their preparation and therapeutic compositions containing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| RH1 | Patent not in force |